MindRank is a clinical-stage AI-powered drug discovery company focusing on small molecule solutions. By incorporating innovations in machine learning alongside biology and chemistry, it aims to revolutionize drug discovery processes. The company has developed a proprietary drug, MDR-001, which successfully obtained US IND approval in a short timeframe. MindRank collaborates with biopharma companies for AI-enabled drug discovery, producing significant breakthroughs such as the allosteric inhibitor PCC. Their expert team of over 40 scientists possesses extensive experience in drug discovery and has contributed to notable scientific journals, earning accolades like being listed among the '100 to Watch' in Forbes Asia's 2023 report. MindRank's ongoing projects aim to improve the efficacy and success rates of drug development, particularly for hard-to-drug molecular targets.
• recognition in industry awards
• expert scientific team
• collaboration with biopharma
• innovations in machine learning
• focus on small molecule drugs
• accelerates drug discovery process
• clinical-stage ai platform
AI-powered small molecule drug discovery platform accelerating drug development.
Benefits:
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
No ratings available.
AI platform for drug discovery using advanced data analytics and machine learning.
View DetailsAI-powered platform for drug discovery using novel therapeutics and machine learning.
View DetailsCreate spooky beats online with this unique musical game featuring character-based sound mixing.
View Details